BRIEF-Aeterna Zentaris acquires U.S. Promotional rights for prostate cancer blood test

Wed Apr 27, 2016 7:21pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

April 27 (Reuters) - Aeterna Zentaris Inc

* Aeterna zentaris acquires exclusive u.s. Promotional rights for apifiny prostate cancer blood test Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)